Stocks · Healthcare · Drug Manufacturers - Specialty & Generic
Lantheus Holdings, Inc. LNTH
$99.96 +0.31% Close, Oct 2, 2026 · NASDAQ · Market cap $6.51B
High qualityStrong trendLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to 19.4% from 28.8% a year earlier.
- Over the past year the stock returned +93.6%, ahead of the S&P 500 by 78.5 percentage points.
- The stock is in an uptrend: above its 200-day average for 163 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 34%
- EPS growth (TTM, YoY)Top 49%
- FCF growth (TTM, YoY)Bottom 27%
- Revenue growth, 3-year CAGRTop 34%
- Revenue growth accelerationTop 30%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 13%
- Gross marginBottom 46%
- Operating marginTop 14%
- Cash conversion (OCF / net income)Bottom 45%
- Accruals (lower is better)Bottom 45%
- Net debt / EBITDA (lower is better)Top 37%
- Interest coverTop 11%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 13%
- Free-cash-flow yieldTop 15%
- EBITDA / enterprise valueTop 16%
- Sales / enterprise valueTop 48%
- P/E vs own 5-year history (lower is better)Bottom 32%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 19%
- 6-month returnTop 31%
- 1-year return vs S&P 500Top 17%
- Distance from 52-week highTop 17%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 24%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 23%
- Upside to consensus price targetBottom 13%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 2%
- Maximum drawdown, 3 yearsTop 34%
- Beta vs S&P 500 (lower is better)Top 11%
- Net debt / EBITDA (lower is better)Top 37%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 0.6% | 2.3% | ↑ |
| EPS growth (YoY) | 17.9% | 10.1% | ↓ |
| Gross margin | 63.7% | 60.1% | ↓ |
| Operating margin | 28.8% | 19.4% | ↓ |
| FCF margin | 31.0% | 24.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 2.3% | 0.6% | ↑ | Bottom 34% |
| EPS growth (TTM, YoY) | 10.1% | 17.9% | ↓ | Top 49% |
| Gross margin | 60.1% | 63.7% | ↓ | Bottom 46% |
| Operating margin | 19.4% | 28.8% | ↓ | Top 14% |
| Net margin | 17.7% | 17.8% | ↓ | — |
| Free-cash-flow margin | 24.9% | 31.0% | ↓ | — |
| Return on invested capital | 11.0% | — | Top 13% | |
| Revenue growth, 3-year CAGR | 18.1% | — | Top 34% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.50×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +2.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.07×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 15.3×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 2.86%
- Shareholder yield
- 2.86%
- Share count change, 1 year
- -4.0%
- Share count change, 3-year CAGR
- -1.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +19.4%
- Average 2-day reaction, last 8
- -7.2%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $104.48
- Target vs current price
- +4.5%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 58%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +19.2% | -0.4% | -0.8% | -0.7% | — |
| May 7, 2026 | +16.8% | +5.6% | +12.0% | +19.3% | +17.5% |
| Feb 26, 2026 | +41.5% | -0.4% | +2.8% | -0.1% | +24.8% |
| Nov 6, 2025 | +0.0% | -6.2% | -4.8% | +8.1% | +15.3% |
| Aug 6, 2025 | -4.3% | -28.6% | -25.8% | -24.1% | -23.1% |
| May 7, 2025 | -8.9% | -23.2% | -24.7% | -24.0% | -32.7% |
| Feb 26, 2025 | +0.6% | +16.5% | +22.6% | +24.6% | -6.1% |
| Nov 6, 2024 | +9.0% | -20.7% | -25.9% | -22.7% | -20.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $1.55 | $1.30 | +19.2% | $388.2M |
| May 7, 2026 | $1.46 | $1.25 | +16.8% | $377.3M |
| Feb 26, 2026 | $1.67 | $1.18 | +41.5% | $406.8M |
| Nov 6, 2025 | $1.27 | $1.27 | +0.0% | $384.0M |
| Aug 6, 2025 | $1.57 | $1.64 | -4.3% | $378.0M |
| May 7, 2025 | $1.53 | $1.68 | -8.9% | $372.8M |
| Feb 26, 2025 | $1.59 | $1.58 | +0.6% | $391.1M |
| Nov 6, 2024 | $1.70 | $1.56 | +9.0% | $378.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 24.1× | 22.5× | 63th | Top 13% |
| P/E (forward) | 18.5× | — | — | — |
| EV / EBITDA | 14.1× | — | — | Top 16% |
| EV / Sales | 4.20× | — | — | Top 48% |
| Free-cash-flow yield | 5.96% | — | — | Top 15% |
| Earnings yield | 4.14% | — | — | Top 13% |
P/E over the past five years
Range 11.9× – 205.8× since Jun 30, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +93.6%
- Earnings per share growth (TTM)
- +10.1%
- Change in P/E multiple
- +76.9%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 163
- 50-day average slope (20 days)
- -2.4%
- 200-day average slope (20 days)
- +4.9%
- Distance from 50-day average
- -0.8%
- Distance from 200-day average
- +13.5%
- RSI (14)
- 44.8
- Relative volume
- 0.71×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 20.7%
- Volatility vs own 5-year history
- 0th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.37
- Correlation with S&P 500
- 0.12
- Current drawdown from 1-year high
- -9.9%
- Maximum drawdown, 3 years
- -59.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jul 11, 2024 | Sep 22, 2025 | -59.5% | 300 days | Not yet recovered |
| May 12, 2023 | Jan 24, 2024 | -48.8% | 175 days | 115 days (Jul 10, 2024) |
| Aug 25, 2022 | Jan 9, 2023 | -44.9% | 93 days | 65 days (Apr 13, 2023) |
| Oct 7, 2020 | Nov 5, 2020 | -22.4% | 21 days | 22 days (Dec 8, 2020) |
| Jul 1, 2021 | Oct 27, 2021 | -21.2% | 82 days | 7 days (Nov 5, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $6.51B
- P/E (TTM)
- 24.1
- EPS, diluted (TTM)
- $4.14
- Revenue (TTM)
- $1.56B
- 52-week range
- $49.67 – $111.86
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $425.2M | $935.1M | $1.30B | $1.53B | $1.54B |
| Gross profit | $187.7M | $581.7M | $709.5M | $988.3M | $942.0M |
| Operating income | -$60.8M | $36.2M | $364.6M | $457.0M | $310.8M |
| Net income | -$71.3M | $28.1M | $326.7M | $312.4M | $233.6M |
| EPS (diluted) | -$1.06 | $0.40 | $4.65 | $4.36 | $3.41 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $378.7M | $391.1M | $372.8M | $378.0M | $384.0M | $406.8M | $377.3M | $388.2M |
| Net income | $131.1M | -$11.8M | $72.9M | $78.8M | $27.8M | $54.1M | $118.4M | $75.0M |
| EPS (diluted) | $1.79 | -$0.17 | $1.02 | $1.12 | $0.41 | $0.82 | $1.80 | $1.11 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $53.9M | $281.8M | $305.3M | $544.8M | $390.1M |
| Capital expenditure | -$12.1M | -$18.3M | -$46.6M | -$51.6M | -$36.1M |
| Free cash flow | $41.8M | $263.4M | $258.7M | $493.1M | $354.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $767,000 | -$73.6M | $1.9M | -$96.5M | -$289.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $593.3M
- Total assets
- $2.41B
- Total liabilities
- $1.10B
- Total debt
- $625.0M
- Net debt
- $31.7M
- Shareholders’ equity
- $1.31B
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 4,036,832
- Days to cover
- 4.07
- Change vs previous report
- -4.7%
FINRA short interest, settlement date Sep 15, 2026.